22 February 2018 (Thursday) - Oncologist Newsletter

The Oncologist Newsletter arrived in my in-box today


The Oncologist Banner
The Oncologist
Access the Most-Read Research from The Oncologist
In a constantly changing field, hematology and oncology professionals must stay at the cutting edge of new diagnostic and therapeutic advances for the benefit of their patients. To that end, The Oncologist is committed to helping clinicians improve outcomes for their patients, and we are pleased to provide you with complimentary access to our most-read content.

Register and Read The Oncologist
Receive New Content Alerts
Most-Read Articles in Hematology Oncology
FDA Approval Summary: Daratumumab for Treatment of Multiple Myeloma After One Prior Therapy
Vishal Bhatnagar, Nicole J. Gormley, Lola Luo, Yuan Li Shen, Rajeshwari Sridhara, Sriram Subramaniam, Guoxiang Shen, Lian Ma, Stacy Shord, Kirsten B. Goldberg, Ann T. Farrell, Amy E. McKee, Richard Pazdur
Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents
Bruce D. Cheson, Sari Heitner Enschede, Elisa Cerri, Monali Desai, Jalaja Potluri, Nicole Lamanna, Constantine Tam
Best Practices in Chronic Myeloid Leukemia Monitoring and Management
Simona Soverini, Caterina De Benedittis, Manuela Mancini, Giovanni Martinelli
Most-Read Articles in Medical Oncology
Transitions in Prognostic Awareness Among Terminally Ill Cancer Patients in Their Last 6 Months of Life Examined by Multi‐State Markov Modeling
Chen Hsiu Chen, Fur‐Hsing Wen, Ming‐Mo Hou, Chia‐Hsun Hsieh, Wen‐Chi Chou, Jen‐Shi Chen, Wen‐Cheng Chang, Siew Tzuh Tang
Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations
Laura M. Spring, Mark L. Zangardi, Beverly Moy, Aditya Bardia
Preventing and Managing Toxicities of High-Dose Methotrexate
Scott C. Howard, John McCormick, Ching-Hon Pui, Randall K. Buddington, R. Donald Harvey

No comments:

Post a comment